Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	45.75	-48.15	-88.76
Graham Fair Price	41.43	0.17	0.12
PEG	-97.33	-0.04	1.32
Price/Book	7.50	10.46	9.73
Price/Cash Flow	69.43	-137.39	-449.37
Prices/Earnings	46.25	-3.50	-6.51
Price/Sales	-46.25	1.84	3.42
Price/FCF	69.43	-137.39	-449.37
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.04	0.04
Operating Margin	< 0.005	-0.09	-0.09
ROA	-100.00	-0.05	-0.02
ROE	-0.37	-0.75	-100.00
ROIC	-0.02	-0.05	-99.34
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.06	-91.10
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.75	-1.00	32.91
EPS QOQ	0.05	-0.99	1911.85
FCF QOQ	-1.04	-2.52	-140.79
Revenue QOQ	-0.60	1.00	67.80
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	5.30	2.65	-50.00
Days Sales Outstanding (DSO)	14.46	10.68	-26.18
Inventory Turnover	16.99	33.97	100.00
Debt/Capitalization	0.91	0.91	0.05
Quick Ratio	0.73	0.82	12.04
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.04	0.04	< 0.005
Cash	0.06	0.06	< 0.005
Capex	< 0.005	< 0.005	-100.01
Free Cash Flow	< 0.005	< 0.005	-251.61
Revenue	0.12	0.23	100.01
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.26	1.26	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-41.95	-21.96	47.65
Naive Interpretation	Member

06 - Financial Health · Weak

Rating